Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AstraZeneca : Correction to AstraZeneca Vaccine Article

11/24/2020 | 02:01pm EST

Emergent BioSolutions Inc. is based in Gaithersburg, Md. "AstraZeneca Gears Up to Vaccinate the World Against Covid-19" at 8:54 a.m. ET, incorrectly said the company was based in Rockville, Md.

(END) Dow Jones Newswires

11-24-20 1400ET

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.44% 7592 Delayed Quote.3.21%
EMERGENT BIOSOLUTIONS INC. 1.26% 107.3 Delayed Quote.18.29%
All news about ASTRAZENECA PLC
11:29aASTRAZENECA : Deutsche Bank Initiates Coverage on AstraZeneca With Buy Rating
MT
11:10aEuropean ADRs Move Sharply Lower in Friday Trading
MT
07:36aSouth Africa's mining industry to support COVID-19 vaccine rollout
RE
07:28aASTRAZENECA : Nepal clears AstraZeneca vaccine for emergency use
AQ
06:00aASTRAZENECA : Buy rating from Deutsche Bank
MD
04:38aASTRAZENECA : Obtains European Approval for Imfinzi's Expanded Dosing Option
MT
03:48aASTRAZENECA : Buy rating from Berenberg
MD
03:19aAstraZeneca lung cancer drug gets nod for new dosing regimen in EU, UK
RE
02:25aASTRAZENECA : Additional Dosing Option for Imfinzi Lung Cancer Treatment Approve..
MT
02:04aASTRAZENECA : Imfinzi approved in the EU for less-frequent, fixed-dose use in un..
PU
More news
Financials (USD)
Sales 2020 26 397 M - -
Net income 2020 2 992 M - -
Net Debt 2020 13 217 M - -
P/E ratio 2020 43,1x
Yield 2020 2,72%
Capitalization 136 B 136 B -
EV / Sales 2020 5,64x
EV / Sales 2021 4,90x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 126,21 $
Last Close Price 103,42 $
Spread / Highest target 50,9%
Spread / Average Target 22,0%
Spread / Lowest Target -18,7%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC3.21%135 863
JOHNSON & JOHNSON2.08%422 918
ROCHE HOLDING AG0.99%301 476
NOVARTIS AG-0.16%214 006
MERCK & CO., INC.0.45%207 893
PFIZER INC.-0.16%204 271